首页> 外文OA文献 >Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
【2h】

Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.

机译:食盐缺乏/食盐正常的低剂量志愿者对低剂量静脉注射培哚普利拉输注的反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Intravenous ACE inhibitor therapy appears to have a role in the treatment of acute heart failure and early after myocardial infarction. Practical experience with intravenous administration with activation of renin is limited. We report responses to perindoprilat (Pt, 0.67 mg) or placebo (P) infused over 4 h in normotensive male volunteers (n = 12, 19-28 years, 53-77 kg) with double-blind, placebo controlled salt depletion (SD) or salt repletion (SR) as a model of the activated renin system. 2. Salt depletion caused no significant fall in serum sodium (P, 139.4 +/- 2.4; Pt, 138.3 +/- 1.9) compared with salt replete preparation (P, 139.9 +/- 1.2; Pt, 139.7 +/- 0.9) but elevation of plasma renin activity 2-3-fold. Pretreatment baseline systolic blood pressure following salt depletion (P, 121 +/- 9.3/71 +/- 7.9; Pt, 121.5 +/- 9.6/69 +/- 8.1) was higher than following salt replete preparation (P, 114 +/- 9.5/61 +/- 7.2; Pt, 116.9 +/- 6.9/67 +/- 7.2). 3. Baseline corrected supine SBP fell significantly and to a similar extent following active treatment regardless of activation of the renin system (SD, -14.6 +/- 9.5/-9.4 +/- 6.4; SR, -12 +/- 14/-10.1 +/- 6.6) compared with placebo (SD, -6.1 +/- 6/-3.7 +/- 5.6; SR, -4.7 +/- 10/-1.3 +/- 6.5). Heart rate was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.静脉ACE抑制剂治疗似乎在急性心力衰竭和心肌梗塞后早期治疗中起作用。静脉注射肾素激活的实践经验有限。我们报道了在血压正常的男性志愿者(n = 12、19-28岁,53-77 kg)中用双盲,安慰剂控制的盐耗(SD)在4 h内输注perindoprilat(Pt,0.67 mg)或安慰剂(P)的反应)或盐补充(SR)作为激活的肾素系统的模型。 2.与食盐补充制剂(P,139.9 +/- 1.2; Pt,139.7 +/- 0.9)相比,食盐缺乏不会引起血清钠的显着下降(P,139.4 +/- 2.4; Pt,138.3 +/- 1.9)。但血浆肾素活性升高2-3倍。食盐减量后的治疗前基线收缩压(P,121 +/- 9.3 / 71 +/- 7.9; Pt,121.5 +/- 9.6 / 69 +/- 8.1)高于充盐后的预后(P,114 + / -9.5 / 61 +/- 7.2;铂,116.9 +/- 6.9 / 67 +/- 7.2)。 3.基线治疗后的仰卧SBP显着下降,并且在积极治疗后下降幅度相似,无论肾素系统是否激活(SD,-14.6 +/- 9.5 / -9.4 +/- 6.4; SR,-12 +/- 14 /-与安慰剂相比(10.1 +/- 6.6)(SD,-6.1 +/- 6 / -3.7 +/- 5.6; SR,-4.7 +/- 10 / -1.3 +/- 6.5)。心率未变(摘要以250字截断)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号